Literature DB >> 16460002

Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis, snapshots of the enzyme in action.

Shuishu Wang1, David Eisenberg.   

Abstract

Pantothenate synthetase (PS) from Mycobacterium tuberculosis represents a potential target for antituberculosis drugs. PS catalyzes the ATP-dependent condensation of pantoate and beta-alanine to form pantothenate. Previously, we determined the crystal structure of PS from M. tuberculosis and its complexes with AMPCPP, pantoate, and pantoyl adenylate. Here, we describe the crystal structure of this enzyme complexed with AMP and its last substrate, beta-alanine, and show that the phosphate group of AMP serves as an anchor for the binding of beta-alanine. This structure confirms that binding of beta-alanine in the active site cavity can occur only after formation of the pantoyl adenylate intermediate. A new crystal form was also obtained; it displays the flexible wall of the active site cavity in a conformation incapable of binding pantoate. Soaking of this crystal form with ATP and pantoate gives a fully occupied complex of PS with ATP. Crystal structures of these complexes with substrates, the reaction intermediate, and the reaction product AMP provide a step-by-step view of the PS-catalyzed reaction. A detailed reaction mechanism and its implications for inhibitor design are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460002     DOI: 10.1021/bi051873e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

Review 1.  Adenylating enzymes in Mycobacterium tuberculosis as drug targets.

Authors:  Benjamin P Duckworth; Kathryn M Nelson; Courtney C Aldrich
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

2.  Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.

Authors:  Hernani Leonardo Silvestre; Thomas L Blundell; Chris Abell; Alessio Ciulli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-19       Impact factor: 11.205

3.  Solution structure of the N-terminal domain of DC-UbP/UBTD2 and its interaction with ubiquitin.

Authors:  Ai-Xin Song; Chen-Jie Zhou; Xiao Guan; Kong-Hung Sze; Hong-Yu Hu
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

4.  Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.

Authors:  Zhixiang Xu; Wei Yin; Leonardo K Martinelli; Joanna Evans; Jinglei Chen; Yang Yu; Daniel J Wilson; Valerie Mizrahi; Chunhua Qiao; Courtney C Aldrich
Journal:  Bioorg Med Chem       Date:  2014-01-23       Impact factor: 3.641

Review 5.  Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery.

Authors:  Zhiyong Lou; Xiaoxue Zhang
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

6.  Pantothenic acid biosynthesis in the parasite Toxoplasma gondii: a target for chemotherapy.

Authors:  Sarmad N Mageed; Fraser Cunningham; Alvin Wei Hung; Hernani Leonardo Silvestre; Shijun Wen; Tom L Blundell; Chris Abell; Glenn A McConkey
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

7.  Cavitation as a mechanism of substrate discrimination by adenylosuccinate synthetases.

Authors:  Cristina V Iancu; Yang Zhou; Tudor Borza; Herbert J Fromm; Richard B Honzatko
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

8.  Biosynthesis of Pantothenic Acid and Coenzyme A.

Authors:  Roberta Leonardi; Suzanne Jackowski
Journal:  EcoSal Plus       Date:  2007-04

9.  FLORA: a novel method to predict protein function from structure in diverse superfamilies.

Authors:  Oliver C Redfern; Benoît H Dessailly; Timothy J Dallman; Ian Sillitoe; Christine A Orengo
Journal:  PLoS Comput Biol       Date:  2009-08-28       Impact factor: 4.475

10.  Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate.

Authors:  Alessio Ciulli; Duncan E Scott; Michiyo Ando; Fernando Reyes; S Adrian Saldanha; Kellie L Tuck; Dimitri Y Chirgadze; Tom L Blundell; Chris Abell
Journal:  Chembiochem       Date:  2008-11-03       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.